Back

A novel neural stem cell-derived immunocompetent mouse model of glioblastoma for preclinical studies

Costa, B.; Fletcher, M. N.; Boskovic, P.; Ivanova, E. L.; Eisemann, T.; Lohr, S.; Bunse, L.; Loewer, M.; Burchard, S.; Korshunov, A.; Liu, H.-K.; Platten, M.; Radlwimmer, B.; Angel, P.; Peterziel, H.

2020-03-16 cancer biology
10.1101/2020.03.16.993196 bioRxiv
Show abstract

Glioblastomas are the most lethal tumors affecting the central nervous system in adults. Simple and inexpensive syngeneic in vivo models that closely mirror human glioblastoma, including interactions between tumor and immune cells, are urgently needed for deciphering glioma biology and developing more effective treatments. Here, we generated glioblastoma cell lines by repeated in-vivo passaging of cells isolated from a neural stem cell-specific Pten/p53 double-knockout genetic mouse brain tumor model. Transcriptome and genome analyses of the cell lines revealed molecular heterogeneity comparable to that observed in human glioblastoma. Upon orthotopic transplantation into syngeneic hosts they formed high-grade gliomas that faithfully recapitulated the histopathological features, invasiveness and myeloid cell infiltration characteristic of human glioblastoma. These features make our cell lines unique and useful tools to study multiple aspects of glioblastoma pathomechanism and test novel treatments, especially immunotherapies in syngeneic preclinical models.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.